Fujian Wanchen Biotechnology Group Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Other Agricultural Products
  • ISIN: CNE100004KH1
CNY
227.94
5.94 (2.68%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
16,634.41
14,896.84
13,979.75
11,761.69
10,820.88
11,715.73
9,697.87
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
16,634.41
14,896.84
13,979.75
11,761.69
10,820.88
11,715.73
9,697.87
Raw Material Cost
14,493.75
12,825.79
12,319.64
10,421.06
9,671.76
10,434.78
8,746.14
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
20.44
12.36
11.94
12.54
17.23
14.01
13.42
Selling and Distribution Expenses
891.41
938.47
716.24
651.53
591.70
847.41
626.80
Other Expenses
-0.44
0.80
0.05
-1.17
-1.65
-1.33
-1.27
Total Expenditure (Excl Depreciation)
15,401.17
13,784.62
13,048.30
11,073.42
10,264.19
11,282.87
9,373.69
Operating Profit (PBDIT) excl Other Income
1233.1999999999998
1112.2
931.4
688.3
556.7
432.9
324.20000000000005
Other Income
122.87
46.21
69.68
42.62
13.79
69.69
14.90
Operating Profit (PBDIT)
1,304.58
1,184.23
1,030.72
771.29
616.24
542.73
392.36
Interest
20.44
12.36
11.94
12.54
17.23
14.01
13.42
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
2,140.66
2,071.04
1,660.11
1,340.63
1,149.12
1,280.95
951.73
Depreciation
0.00
65.50
65.50
75.40
75.40
70.60
70.60
Profit Before Tax
1,284.15
1,106.37
953.28
683.35
523.61
458.12
308.34
Tax
316.39
273.24
232.80
201.02
135.64
199.54
107.44
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
629.78
489.62
383.41
256.71
214.85
209.46
83.13
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
629.78
489.62
383.41
256.71
214.85
209.46
83.13
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
337.98
343.51
337.07
225.62
173.12
49.12
117.77
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
967.76
833.13
720.48
482.33
387.97
258.58
200.90
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,016.36
1,483.25
2,041.76
1,622.14
1,323.81
1,098.15
912.98
Earnings per share (EPS)
3.12
2.43
1.9
1.35
1.19
1.1
0.44
Diluted Earnings per share
3.12
2.43
1.9
1.35
1.19
1.1
0.44
Operating Profit Margin (Excl OI)
7.1%
7.2%
6.41%
5.55%
4.87%
3.44%
3.16%
Gross Profit Margin
7.72%
7.87%
7.29%
6.45%
5.54%
4.51%
3.91%
PAT Margin
3.79%
3.29%
2.74%
2.18%
1.99%
1.79%
0.86%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 53.72% vs 124.02% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 149.43% vs 461.51% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 96.17% vs 238.05% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is 18.60% vs 45.76% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Fujian Wanchen Biotechnology Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
16,634.41
0
16,634.41
Other Operating Income
0.00
0.00
0.00
Total Operating income
16,634.41
0
16,634.41
Raw Material Cost
14,493.75
0
14,493.75
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
20.44
0
20.44
Selling and Distribution Expenses
891.41
0
891.41
Other Expenses
-0.44
0.00
-0.44
Total Expenditure (Excl Depreciation)
15,401.17
0
15,401.17
Operating Profit (PBDIT) excl Other Income
1,233.24
0.00
1,233.24
Other Income
122.87
0
122.87
Operating Profit (PBDIT)
1,304.58
0
1,304.58
Interest
20.44
0
20.44
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
2,140.66
0
2,140.66
Depreciation
0.00
0
0.00
Profit Before Tax
1,284.15
0
1,284.15
Tax
316.39
0
316.39
Provisions and contingencies
0
0
0.00
Profit After Tax
629.78
0
629.78
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
629.78
0
629.78
Share in Profit of Associates
0
0
0.00
Minority Interest
337.98
0
337.98
Other related items
0.00
0.00
0.00
Consolidated Net Profit
967.76
0
967.76
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,016.36
0
2,016.36
Earnings per share (EPS)
3.12
0
3.12
Diluted Earnings per share
3.12
0
3.12
Operating Profit Margin (Excl OI)
7.10%
0%
0.00
7.10%
Gross Profit Margin
7.72%
0%
0.00
7.72%
PAT Margin
3.79%
0%
0.00
3.79%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,663.44 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 11.66% vs 6.56% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 53.72% vs 124.02% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 96.78 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 16.17% vs 15.63% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 149.43% vs 461.51% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 118.17 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 3.84% vs 18.42% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 96.17% vs 238.05% in Mar 2025

Quarterly - Interest
Interest 2.04 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 64.52% vs 4.20% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 18.60% vs 45.76% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.10%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025